HCPToday

The landscape of aesthetic dermatology is undergoing a transformative shift as we harness epigenetics to unlock longevity. Recent research highlights the role of epigenetic clocks in personalizing treatments, offering a molecular basis for rejuvenation strategies. By understanding how lifestyle factors and technology can reverse aging at the cellular level, we can innovate our marketing approach and drive patient engagement. Explore the potential of data-driven personalization in your strategies today!

Epigenetic Clocks and Personalized Approaches in Skin Aging The following is a summary of “Unlocking Longevity in Aesthetic Dermatology: Epigenetics, Aging, and Personalized Care,” published in the March 2025 issue...

The healthcare landscape is shifting, particularly in primary care, where physician burnout and patient dissatisfaction are rampant. At MaineHealth, we've initiated bold changes, transitioning towards capitated models that prioritize patient relationships over transactional care. The results? Higher team satisfaction and promising patient feedback. To thrive, we must embrace radical change in our reimbursement models and EHR systems. Join the conversation on redefining primary care for a healthier future.

The urgent need for better primary care: Why health systems must embrace change

Odronextamab (Ordspono) shows promise as a monotherapy for diffuse large B-cell lymphoma (DLBCL) patients who have progressed after CAR T-cell therapy, achieving an overall response rate of 48% and a complete response rate of 32%. The ELM-1 study indicates that treatment is generally manageable, with cytokine release syndrome being the most common adverse event.

Odronextamab Shows Efficacy in DLBCL Post CAR T-Cell Therapy Matthew Matasar, MD, discussed what the findings from the ELM-1 trial of odronextamab in diffuse large B-cell lymphoma mean for oncologists.

Healthcare marketing isn't just about promoting services; it's about understanding the patient journey deeply. William's story highlights the critical role of effective communication and timely diagnosis in healthcare. As marketers, we must ensure that our strategies empower patients and their families to advocate for themselves. By harnessing data insights and engaging narratives, we can build trust and enhance the patient experience. Let's drive change together!

William’s Journey: Tiptoeing Through the Long Road to a DMD Diagnosis - Rare Disease Advisor Duchenne muscular dystrophy (DMD) was not something that crossed our minds at first, and it certainly wasn’t something doctors suggested early on.